Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Echo Therapeutics posts a tough quarter | Earnings Roundup

Echo Therapeutics posts a tough quarter | Earnings Roundup

By

Echo Therapeutics

 Echo Therapeutics Inc.’s (OTC:ECTE) grew more than three fold in Q2 as the company poured money into research & development and administrative expenses.

Losses for the quarter widened 262 percent to $1.9 million, or a loss of 6 cents per diluted share, during the three months ended June 30, compared to losses of $536,000, or 2 cents lost per diluted share, during the same period last year.

The Philadelphia-based drug-delivery systems maker posted a 40 percent dip in sales to $158,520, compared to $264,199 sold during the same Q2 2010, according to a press release.

Echo Therapeutics, which announced that its shares were listed the NASDAQ Capital Market exchange one day before the close of the quarter, spent nearly $800,000 more on operations this quarter than in the same period last year as it aims to push its Symphony transdermal continuous glucose monitoring system through clinical trials.

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Tornier narrows losses in Q2
Tornier N.V. (NSDQ:TRNX) losses narrowed dramatically in the three months ended July 3. The Amsterdam-based orthopedic company posted a 19 percent incrase in sales to $65.2 million, compared to $54.7 million during the same period last year.

Company losses shrank 67 percent to $2.9 million, or a loss of 7 cents per diluted share, compared to $8.6 million lost, or a loss of 31 cents per diluted share in Q2 of 2010.
Read more

Thergenics boosts earnings
Theragenics Corp. (NYSE:TGX) saw an earnings bump in the three months ended June 30. The Buford, Ga.-based surgical products and prostate cancer company posted a 4 percent increase in sales to $21.5 million, compared to $20.8 million during the same period last year.

Company profits jumped 52 percent to $1.2 million, or 4 cents per diluted share, compared to $782,000, or 2 cents per diluted share in Q2 of 2010.
Read more

TranS1 sinks in Q2
TranS1 Inc. (NSDQ:TSON) saw heavy losses in the three months ended June 30. The Wilmington, N.C.-based spinal company posted a 26 percent decrease in sales to $5.3 million, compared to $7.2 million during the same period last year.

Company losses widened 19 percent to $4.3 million, or a loss of 21 cents per diluted share, compared to $3.6 million, or 18 cents per diluted share in Q2 of 2010.
Read more

IntriCon dives into the red
IntriCon Corp. (NSDQ:IIN) saw a dramatic dive in the three months ended June 30. The Arden Hills, Minn.-based maker of mini and micro-mini wearable devices posted a 7 percent decrease in sales to $14 million, compared to $15 million during the same period last year.

Company profits fell $294,000 into the red, or lost 5 cents per diluted share, compared to $$269,000, or 5 cents earned per diluted share in Q2 of 2010.
Read more

    Bovie sinks deeper into the red
    Bovie Medical Corp. (NYSE:BVX) saw healthy sales growth and widened losses in the three months ended June 30. The Melville, N.Y.-based electrosurgical company posted a 16 percent increase in sales to $6,841, compared to $5,987 during the same period last year.

    Company losses soared 666 percent to $429,000, or a loss of 2 cents per diluted share, compared to a loss of $56,000, with neutral share earnings, in Q2 of 2010.
    Read more

    Invivo posts triple losses
    InVivo Therapeutics (OTC:NVIV) saw dramatically widened losses in the three months ended June 30. The Cambridge, Mass.-based early-stage spinal company posted had no sales to post.

    Company expenses grew 41 percent to $1.4 million, compared to $970,445 lost in Q2 of 2010. Losses per diluted share stayed steady at 3 cents.
    Read more

    Vision Sciences widens losses on strong sales
    Vision Sciences Inc. (NSDQ:VSCI) saw strong sales growth in the three months ended June 30. The Orangeburg, N.Y.-based endoscopy company posted a 43 percent boost in sales to $3.8 million, compared to $2.6 million during the same period last year.

    Company losses widened 7 percent to $2.6 million, or a loss of 6 cents per diluted share, compared to $2.5 million, or 7 cents lost per diluted share in Q2 of 2010.
    Read more

    Bioject kills it in Q2
    Bioject Medical Technologies Inc. (OTC:BJCT)  saw huge boosts in the three months ended June 30. The Portland, Ore.-based needle-free drug delivery systems company posted a 107 percent leap in sales to $2.4 million, compared to $1.2 million during the same period last year.

    The company climbed out of the red, postign profits of $274,000, or 1 cent per diluted share, compared to losses of $556,000, or 3 cents lost per diluted share in Q2 of 2010.
    Read more

    Cardica sales look good in Q4 and great for FY 2011, but the company stays in the red
    Cardica Inc. (NSDQ:CRDC) saw great sales in FY 2011, posting a 232 bump to $13.2 million, compared to $4 million in sales in 2010. Fourth quarter 2011 sales came in 5 percent higher than the same period last year with $1.04 million compared to $991,000 for Q4 2010.

    The Redwood City, Calif.-based stapling and anastomotic devices company posted a 7 percent decrease in losses to $2.8 million for fourth quarter, compared to $3.1 million lost during the same period last year.

    Company losses for 2011 narrowed 68 percent to $3.5 million, or a loss of 14 cents per diluted share, compared to $11 million lost, or 50 cents lost per diluted share in 2010.
    Read more

    World Heart sees sinking sales, earnings; ends Levacor ventricular assist device program
    World Heart Corp. (NSDQ:WHRT) saw a hard quarter in the three months ended June 30. The Salt Lake City, Utah-based ventricular assist device company posted a 97 percent sink in sales to $14,139, compared to $467,428 during the same period last year. The company announced that it tabled its Levacor ventricular assist device technology to focus on a new generation MiFlow VAD.

    Company losses narrowed 44 percent to $1.5 million, or 6 cents lost cents per diluted share, compared to $2.7 million, or 19 cents per diluted share in Q2 of 2010.
    Read more

    Kip’s Bay narrows losses
    Kip’s Bay Medical Inc. (NSDQ:KIPS) cut expenses in the three months ended July 2. The Minneapolis, Minn-based company posted a steady sales of $48,000, the same as during the same period last year.

    Company losses narrowed 82 percent to $1.04 million, or 7 cents lost per diluted share, compared to $5.9 million, or 43 lost cents per diluted share in Q2 of 2010.
    Read more

    Tiger X Medical posts in the black on buyout
    Tiger X Medical Inc. saw a huge boost thanks to a buyout in the three months ended June 30. The Van Nuys, Calif.-based company posted a 11.4 million in earnings on no revenues, compared to $1.5 million lost.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • FDA seeks feedback on pre-determined change control plans for AI/ML devices
    The FDA is responding to an ever-growing list of medical devices enabled by artificial intelligence and machine learning with new recommendations for updating AI and ML software models with pre-determined change control plans (PCCPs). A key benefit of ML models is that they can learn to work better based on new information over time, but… […]
  • Researchers develop biodegradable artificial muscles for soft robotics
    Scientists across Germany, Austria and the U.S. say their biodegradable artificial muscles could improve the field of soft robotics. Researchers from Stuttgart, Germany; Linz Austria; and Boulder, Colorado, said artificial muscles could one day enable robots to function like living organisms. These muscles may create new possibilities for the way in which robots shape the… […]
  • Zimmer Biomet’s R&D team grows, manufacturing and total workforce shrinks after ZimVie spinoff
    Zimmer Biomet (NYSE:ZBH) has more R&D employees following the ZimVie spinoff but fewer total employees, including manufacturing employees and employees in the U.S. Warsaw, Indiana-based Zimmer Biomet spun its spine and dental business off as ZimVie (Nasdaq:ZIMV) in March 2022. Westminster, Colorado-based ZimVie said in its first-ever annual report this month that it has approximately… […]
  • This implantable fuel cell generates electricity from glucose
    A team of researchers developed an implantable fuel cell that uses excess glucose from tissue to generate electrical energy. By combining the fuel cell with artificial beta cells, the team produced insulin with the touch of a button. This effectively lowered blood glucose levels like the natural process in the pancreas. Given that current treatments… […]
  • Ulbrich launches all-in-one metals calculator and conversion app for manufacturers
    NEWS RELEASE: Ulbrich Launches All-in-One Metals Calculator and Conversion App for Manufacturers North Haven, Connecticut – Ulbrich Stainless Steels & Special Metals, the global leader in precision metal products, has launched its second mobile app — a metals calculator and conversion app with essential tools for engineers, purchasers, and other manufacturing personnel. The app is… […]
  • 11 diabetes tech startups you need to know
    The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps and the artificial pancreas, we’ve seen a lot. Companies are looking for all kinds of ways to make their mark in the world of diabetes. Newer offerings include digital health, software, coaching and more. For companies still in their… […]
  • How bringing on suppliers reduced Tivic Health’s manufacturing costs
    Tivic Health Systems (Nasdaq:TIVC) announced today that a new partnership allowed it to significantly cut manufacturing costs. The company completed the supplier qualification and first article inspection of Microart Services. Microart is one of two new partners the company announced at the end of last year. San Francisco-based Tivic said the qualification and inspection helped… […]
  • Nearshoring in Mexico: the risks, challenges and benefits for medtech developers
    Mexico nearshoring is one way medtech manufacturers are addressing supply chain challenges that surfaced in the COVID-19 pandemic. Nearshoring is similar to offshoring, where a device developer moves some operations out of its home country to cut costs or access new markets. Nearshoring is just offshoring closer to home. Jorge Gonzalez Henrichsen, co-CEO of Brownsville,… […]
  • How virtual reality can improve pediatric care
    VR can help children overcome needle fear and allow pediatricians to improve medical care. Dr. Evelyn Chan, SmileyScope  Needles are involved in the most common office procedures and needle fear is nearly universal in young children. Virtual reality (VR) technology might offer a solution. Studies show nearly two-thirds of children and one-fourth of adults have… […]
  • Opportunity awaits at DeviceTalks Boston
    Medtech faces many challenges, but every challenge presents an opportunity — and DeviceTalks Boston will focus on making the best of them. Leaders like to say every challenge presents an opportunity. It sounds uplifting and offers the benefits of being at least partially true, in life and in medtech. It’s fair to say the medical… […]
  • Ashley McEvoy joins J&J’s top-paid executives
    Johnson & Johnson (NYSE:JNJ) has for the first time disclosed its pay package for EVP Ashley McEvoy, the worldwide chair of medical device subsidiary J&J Medtech. McEvoy’s $7.4 million in total compensation could make her the highest-paid woman in medtech. She’s not the highest-paid woman at J&J, however. J&J reported nearly $8.8 million in total… […]

Copyright © 2023 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy